Aia ʻo India ma kahi o 77 miliona mau maʻi maʻi diabetes, ʻo ka lua kiʻekiʻe loa ma ka honua. ʻO ka maʻi ʻeha wāwae maʻi maʻi kekahi o nā pilikia koʻikoʻi a me ka pōʻino o ka maʻi diabetes a ua wehewehe ʻia ʻo ia ka wāwae i hoʻopilikia ʻia e ka ulceration e pili pū ana me ka neuropathy a me / a i ʻole ka maʻi arterial peripheral o ka lālā haʻahaʻa i ka mea maʻi me ka maʻi diabetes. Ma kahi kokoke, 12-15% me ka maʻi diabetes e loaʻa iā DFU ma ka liʻiliʻi loa i hoʻokahi manawa i ke ola. ʻO 5-24% o lākou e alakaʻi i ka ʻoki ʻana i nā lālā i loko o 6-18 mau mahina ma hope o ka loiloi mua. Piʻi ka pilikia o ka ʻeha wāwae a me ka ʻoki ʻana i nā lālā me ka makahiki a me ka lōʻihi o ka maʻi diabetes. Ua hui pū ʻo Alkem me Rokit Healthcare Inc. e hoʻolaha i ka ʻenehana ma India e kōkua i ka hōʻemi ʻana i ka ʻoki ʻana ma waena o nā mea maʻi DFU e noʻonoʻo ana i ka hopena maikaʻi ʻole o ka ʻoki ʻana i ka maikaʻi o ke ola o ka mea maʻi a me ke kaumaha waiwai pili i ka ʻōnaehana olakino.

Ua ʻōlelo ʻo Mr. Sandeep Singh, Luna Hoʻokele, Alkem Laboratories Ltd., "Ma India, ʻo ka maʻi diabetes kekahi o nā pilikia olakino nui. ʻO ka paʻakikī iā ia iho he mea nui loa ka mālama ʻole ʻia o ka maʻi maʻi wāwae wāwae. Ma kahi o 1 lac poʻe e ʻoki ʻia i kēlā me kēia makahiki a hoʻololi i ka maikaʻi o ko lākou ola. No ka hoʻoponopono ʻana i ka pilikia, ua hui pū ʻo Alkem me Rokit Healthcare Inc., kahi hui hoʻoponopono hou o ka honua, e lawe mai i nā hopena hou no ka mālama ʻana i nā maʻi ʻeha wāwae maʻi.

Hoʻohui hou aʻe, ua ʻōlelo ʻo Mr. Sandeep, "ʻO Alkem, i nā makahiki, ʻo ia ke poʻo mua i ka hāʻawi ʻana i ka mālama maʻi kiʻekiʻe, ma o kāna mau hana hou a me nā hana hoʻomanawanui-centric."

He aha e lawe ʻia mai kēia ʻatikala:

A diabetic foot ulcer is one of the most significant and devastating complications of diabetes and is defined as a foot affected by ulceration that is associated with neuropathy and/or peripheral arterial disease of the lower limb in a patient with diabetes.
to commercialize the technology in India to help reduce amputation amongst DFU patients considering the negative impact of amputation on a patient’s quality of life and the associated economic burden on the healthcare system.
The risk of foot ulceration and limb amputation increases with age and the duration of diabetes.